The North America Cardiovascular Ultrasound Market would witness market growth of 9.5% CAGR during the forecast period (2021-2027).
The growth of the overall market would be propelled by the constant surge in the penetration of preventive medicine and surge in the occurrence of cardiovascular diseases (CVDs). Cardiovascular diseases like coronary heart disease, stroke, and heart attack are the common causes of death in the U.S. In addition, shifting lifestyle patterns have made the global population more vulnerable to CVDs. For example, as per the CDC, 28.2 million individuals were suffering from heart disease in the U.S. Ultrasound technology is utilized to check deformities in the heart’s functioning, like pumping capacity of the heart, plaque, and functioning of valves in the heart.
North America is home to some of the key market players, which is likely to further boost the growth of the regional market in the upcoming years. Factors such as the huge adoption of ultrasound modality in general diagnostics and the surge in the occurrence of lifestyle-related chronic diseases are responsible for the growth of the regional market. As per the American Heart Association, heart disease is responsible for around 14% of deaths in the United States.
Coronary Heart Disease is one of the most common causes of death in the US after Stroke, heart attack, elevated blood pressure, diseases of the arteries, and other cardiovascular diseases. Moreover, favorable initiatives to spread awareness about the diseases are estimated to boost the demand for cardiovascular devices in the region. Thus, these factors collectively will fuel the growth of the regional cardiovascular ultrasound market during the forecast years.
The US market dominated the North America B/W Display Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $80.7 million by 2027. The Canada market is experiencing a CAGR of 7.7% during (2021 - 2027). Additionally, The Mexico market would witness a CAGR of 6.7% during (2021 - 2027).
Based on Display, the market is segmented into Color Display and B/W Display. Based on Technology, the market is segmented into Doppler, 2D and 3D/4D. Based on Type, the market is segmented into Transthoracic echocardiography, Transesophageal echocardiography, Fetal echocardiography and Others. Based on End Use, the market is segmented into Hospital, Diagnostic centers, Ambulatory care centers and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Cardiovascular Ultrasound Market is Estimated to Reach USD 2.6 Billion by 2027 at a CAGR of 10.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Koninklijke Philips N.V., Siemens AG (Siemens Healthineers), Samsung Electronics Co., Ltd. (Samsung Group) (Samsung Medison Co., Ltd.), Mindray Medical International Limited, Chison Medical Technologies Co., Ltd., FUJIFILM Sonosite, Inc. (Fujifilm Holdings Corporation), Canon, Inc. (Canon Medical Systems Corporation) and Esaote SpA.
By Display
By Technology
By Type
By End Use
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
